Transdermal Therapeutics, Inc.   Report issue

For profit Phase 1
Founded: Birmingham AL United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2015
NCT02485145
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now